Medicure Inc. (TSXV:MPH)

Canada flag Canada · Delayed Price · Currency is CAD
1.150
0.00 (0.00%)
Aug 27, 2025, 2:41 PM EDT
Market Cap12.00M
Revenue (ttm)23.20M
Net Income (ttm)-1.35M
Shares Out10.44M
EPS (ttm)-0.13
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,100
Average Volume2,117
Open1.150
Previous Close1.150
Day's Range1.000 - 1.150
52-Week Range0.630 - 1.270
Beta0.91
RSI56.08
Earnings DateAug 20, 2025

About Medicure

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological i... [Read more]

Sector Healthcare
Founded 1997
Employees 38
Stock Exchange TSX Venture Exchange
Ticker Symbol MPH
Full Company Profile

Financial Performance

In 2024, Medicure's revenue was 21.91 million, an increase of 0.98% compared to the previous year's 21.69 million. Losses were -1.04 million, 12.7% more than in 2023.

Financial Statements

News

Medicure GAAP EPS of -$0.08, revenue of $6.7M

Medicure (MCUJF) reports Q2 GAAP EPS of -$0.08 with $6.7M revenue.

11 days ago - Seeking Alpha

Medicure Reports Financial Results for Quarter Ended June 30, 2025

WINNIPEG, MB / ACCESS Newswire / August 20, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and ...

12 days ago - Accesswire

Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025

WINNIPEG, MB / ACCESS Newswire / August 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and ...

14 days ago - Accesswire

Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy

WINNIPEG, MB / ACCESS Newswire / June 17, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals a...

2 months ago - Accesswire

Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results

WINNIPEG, MB / ACCESS Newswire / May 21, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC Pink:MCUJF), a company focused on the development and commercialization of pharmaceuticals an...

3 months ago - Accesswire

Medicure Inc. (MCUJF) Q4 2024 Earnings Call Transcript

Medicure Inc. (OTCPK:MCUJF) Q4 2024 Earnings Call April 29, 2025 8:30 AM ET Company Participants Albert Friesen - Chief Executive Officer Neil Owens - President and Chief Operating Officer Haaris Uddi...

4 months ago - Seeking Alpha

Medicure reports FY results

4 months ago - Seeking Alpha

Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year ...

Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024 | MCUJF Stock News

4 months ago - GuruFocus

Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024

WINNIPEG, MB / ACCESS Newswire / April 22, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals ...

4 months ago - Accesswire

Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy

WINNIPEG, MB / ACCESS Newswire / April 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals ...

5 months ago - Accesswire

Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

WINNIPEG, MB / ACCESS Newswire / March 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals ...

6 months ago - Accesswire

Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

WINNIPEG, MB / ACCESS Newswire / February 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals an...

6 months ago - Accesswire

Medicure GAAP EPS of C$0.07, revenue of C$5.2M

Medicure reported GAAP EPS of C$0.07 and revenue of C$5.2M for the quarter ending September 30, 2024.

9 months ago - Seeking Alpha

Medicure Reports Financial Results For Quarter Ended September 30, 2024

WINNIPEG, MB / ACCESSWIRE / November 25, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals an...

10 months ago - Accesswire

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals an...

10 months ago - Accesswire

Medicure Announces Positive Settlement of Product Development and Supply Contracts

WINNIPEG, MB / ACCESSWIRE / October 24, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and...

11 months ago - Accesswire

Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property

WINNIPEG, MB / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and ...

1 year ago - Accesswire

Medicure Reports Financial Results for Quarter Ended June 30, 2024

WINNIPEG, ON / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and ...

1 year ago - Accesswire

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property

WINNIPEG, MB / ACCESSWIRE / June 24, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and he...

1 year ago - Accesswire

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency

WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and h...

1 year ago - Accesswire

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023

WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and hea...

1 year ago - Accesswire

Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023

WINNIPEG, MB / ACCESSWIRE / April 4, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and he...

1 year ago - Accesswire

Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes

WINNIPEG, MB / ACCESSWIRE / December 5, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and...

1 year ago - Accesswire

Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

WINNIPEG, MB / ACCESSWIRE / November 23, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals an...

1 year ago - Accesswire

Medicure Reports Financial Results for Quarter Ended September 30, 2023

WINNIPEG, MB / ACCESSWIRE / November 21, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals an...

1 year ago - Accesswire